Feb 10 (Reuters) - Indian drugmaker Lupin said on Tuesday it agreed to a $90 million settlement with Japan's Astellas Pharma in a patent dispute over the bladder disorder drug Mirabegron, a move that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results